Infliximab Biosimilar - Research Grade
€ Preis anfragen //= __('Ask for price', \GentaurWPMain\Includes\Gentaur::PLUGIN_ID) ?> //= $prices ?>
Detects human TNF-alpha. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Infliximab.
Low endotoxin, Biosimilar, recombinant antibody
Infliximab biosimilar is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab biosimilar is produced by a recombinant cell line cultured by suspension culture and is purified by a series of steps that includes measures to inactivate and remove viruses.